Hematology

The Myeloproliferative Disorders Group at Mayo Clinic evaluates and treats patients with malignant disease associated with increased production of blood cells (myeloproliferative disorders), including:

• Primary myelofibrosis
• Post-essential thrombocythemia myelofibrosis
• Post-polycythemia vera myelofibrosis
• Polycythemia vera
• Essential thrombocythemia
• Chronic myeloid leukemia
• Chronic myelomonocytic leukemia
• Chronic eosinophilic leukemia
• Systemic mast cell disease
• Chronic neutrophilic leukemia